ELI LILLY & CO (LLY)
Clinical trial NCT07519525 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-01 → 2026-05-26 3. primary completion date: 2026-05-01 → 2026-05-26 4. enrollment: 8 → 7 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical